TOPLINE: Nemolizumab, an interleukin 31 receptor antagonist, was well tolerated and significantly improved inflammation and pruritus in patients with moderate to severe atopic dermatitis (AD). METHODOLOGY: […]

TOPLINE: A new study finds that ultrasound-guided thoracic paravertebral block (TPVB) is more effective than stellate ganglion block (SGB) for treating chronic upper arm pain, providing […]

TOPLINE: A new study of nearly 478,000 UK primary care patients presenting with new abdominal pain or bloating suggests that a cancer referral is warranted if […]

TOPLINE: Published data on laser treatment of nonmelanoma skin cancer (NMSC) is encouraging, although the therapy is not yet approved by the US Food and Drug […]

TOPLINE: Chronic exposure to air pollutants such as fine particulate matter ≤ 2.5 μm in diameter (PM2.5), particulate matter ≤ 10 μm in diameter (PM10), nitrogen […]

TOPLINE: In a network meta-analysis (NMA) from a living systematic review, lebrikizumab and dupilumab showed similar efficacy in patients with atopic dermatitis (AD). METHODOLOGY: Researchers evaluated […]

TOPLINE: A study found significant associations between melasma and several comorbidities, including hypertension and hormonal contraception use, which were the most common. METHODOLOGY: Melasma predominantly affects […]

TOPLINE: A study found significant associations between melasma and several comorbidities, including hypertension and hormonal contraception use, which were the most common. METHODOLOGY: Melasma predominantly affects […]

TOPLINE: Oncologists show significant variability in prescribing systemic cancer therapies in the last 30 days of life. Patients treated by oncologists in the top quartile for […]